Published in Addiction on January 23, 2012
Does long term use of psychiatric drugs cause more harm than good? BMJ (2015) 2.76
Dependence and withdrawal: comparison of the benzodiazepines and selective serotonin re-uptake inhibitors. Addiction (2012) 0.79
Need for a realistic appraisal of benzodiazepines. World Psychiatry (2015) 0.77
Variation and ethnic inequalities in treatment of common mental disorders before, during and after pregnancy: combined analysis of routine and research data in the Born in Bradford cohort. BMC Psychiatry (2016) 0.76
Withdrawal or dependence: a matter of context. Addiction (2012) 0.75
Adaptive and non-adaptive models of depression: A comparison using register data on antidepressant medication during divorce. PLoS One (2017) 0.75
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA (2004) 23.87
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (2007) 20.57
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol (2008) 14.36
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med (2009) 12.16
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80
Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med (2004) 11.47
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med (2007) 10.43
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med (2007) 8.77
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med (2007) 8.46
Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ (2009) 8.31
SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med (2013) 8.21
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med (2007) 7.87
CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol (2010) 7.04
General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev (2012) 6.15
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology (2007) 5.77
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ (2007) 5.38
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology (2007) 5.12
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med (2015) 4.49
Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ (2006) 4.42
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med (2007) 4.29
Opening up data at the European Medicines Agency. BMJ (2011) 3.96
Content of invitations for publicly funded screening mammography. BMJ (2006) 3.71
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg (2011) 3.57
Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review. BMJ (2010) 3.46
Placebo interventions for all clinical conditions. Cochrane Database Syst Rev (2010) 3.45
Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies. BMC Med Res Methodol (2008) 3.11
Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study. BMJ (2004) 3.07
General health checks in adults for reducing morbidity and mortality from disease: Cochrane systematic review and meta-analysis. BMJ (2012) 3.03
Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ (2010) 2.99
Powerful spin in the conclusion of Wampold et al.'s re-analysis of placebo versus no-treatment trials despite similar results as in original review. J Clin Psychol (2007) 2.92
Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia (2013) 2.87
Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study. BMJ (2005) 2.80
Does long term use of psychiatric drugs cause more harm than good? BMJ (2015) 2.76
Prevalence of honorary and ghost authorship in Cochrane reviews. JAMA (2002) 2.58
Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols. BMJ (2008) 2.56
Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study. Lancet Oncol (2011) 2.45
Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort study. PLoS Med (2010) 2.24
Should journals stop publishing research funded by the drug industry? BMJ (2014) 2.13
The journal impact factor as a predictor of trial quality and outcomes: cohort study of hepatobiliary randomized clinical trials. Am J Gastroenterol (2005) 2.12
[Should the announcement of scientific dishonesty be revised yet again?]. Ugeskr Laeger (2013) 2.01
Our prescription drugs kill us in large numbers. Pol Arch Med Wewn (2014) 2.00
[New cancer drugs are no better than old]. Ugeskr Laeger (2013) 1.95
[Overinterpretation of a non-conclusive population study on breast cancer]. Ugeskr Laeger (2004) 1.94
[Are invitations to mammography screening a reasonable basis for informed consent?-- Secondary publication]. Ugeskr Laeger (2006) 1.92
[The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]. Gac Sanit (2008) 1.87
Constraints on publication rights in industry-initiated clinical trials. JAMA (2006) 1.82
Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006. Drug Saf (2009) 1.79
Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality? Radiology (2011) 1.76
Is victimization from bullying associated with medicine use among adolescents? A nationally representative cross-sectional survey in Denmark. Pediatrics (2007) 1.75
General health checks in adults for reducing morbidity and mortality from disease. JAMA (2013) 1.70
Universal health checks should be abandoned. BMJ (2013) 1.67
Electronic monitoring of patient adherence to oral antihypertensive medical treatment: a systematic review. J Hypertens (2009) 1.60
Prescription habits of dispensing and non-dispensing doctors in Zimbabwe. Health Policy Plan (2002) 1.58
[Children's and adolescent's use of medicine for aches and psychological problems: secular trends from 1988 to 2006]. Ugeskr Laeger (2009) 1.49
Registries and registration of clinical trials. N Engl J Med (2005) 1.48
Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention. BMC Med Res Methodol (2009) 1.46
[Comfort and discomfort: the role of emotions in GPs' prescription practices]. Ugeskr Laeger (2005) 1.45
Are benefits and harms in mammography screening given equal attention in scientific articles? A cross-sectional study. BMC Med (2007) 1.43
Citations of scientific results and conflicts of interest: the case of mammography screening. Evid Based Med (2013) 1.42
Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study. Arch Intern Med (2007) 1.40
Lessons from and cautions about noninferiority and equivalence randomized trials. JAMA (2006) 1.40
[Dubious documentation of the effect of acupuncture]. Ugeskr Laeger (2006) 1.39
[Transparency, reliability and conflict of interest]. Ugeskr Laeger (2011) 1.39
[Screening for obsessive thoughts, depression and ADDH?]. Ugeskr Laeger (2013) 1.39
What do we know about the safety of the HPV vaccines? Tidsskr Nor Laegeforen (2017) 1.39
[Information about breast cancer screening presented on websites is biased and insufficient--a secondary publication]. Ugeskr Laeger (2005) 1.38
PRISMA for Abstracts: reporting systematic reviews in journal and conference abstracts. PLoS Med (2013) 1.36
Overdiagnosis in organised mammography screening in Denmark. A comparative study. BMC Womens Health (2009) 1.35
[The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies]. Rev Esp Salud Publica (2008) 1.35
Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs. BMC Clin Pharmacol (2009) 1.33
Information about adverse drug reactions reported in children: a qualitative review of empirical studies. Br J Clin Pharmacol (2010) 1.33
Access to data in industry-sponsored trials. Lancet (2011) 1.28
Biases in estimates of overdetection due to mammography screening. Lancet Oncol (2008) 1.24
Industry-supported meta-analyses compared with meta-analyses with non-profit or no support: differences in methodological quality and conclusions. BMC Med Res Methodol (2008) 1.24
Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory. J Clin Epidemiol (2009) 1.21
Adherence is associated with the quality of professional-patient interaction in Directly Observed Treatment Short-course, DOTS. Patient Educ Couns (2005) 1.20
Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study. BMC Med Ethics (2013) 1.19
Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007. Drug Saf (2010) 1.18
The benefits and harms of screening for cancer with a focus on breast screening. Pol Arch Med Wewn (2010) 1.17
Flawed inferences about screening mammography's benefit based on observational data. J Clin Oncol (2008) 1.17
Using text-mining techniques in electronic patient records to identify ADRs from medicine use. Br J Clin Pharmacol (2012) 1.14
Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?--A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection. Pediatr Pulmonol (2004) 1.13
Caught in a balancing act: parents' dilemmas regarding their ADHD child's treatment with stimulant medication. Qual Health Res (2006) 1.08
Searching for unpublished data for Cochrane reviews: cross sectional study. BMJ (2013) 1.07
[In Process Citation]. Ugeskr Laeger (2015) 1.07
The threatened self: general practitioners' self-perception in relation to prescribing medicine. Soc Sci Med (2004) 1.06
Changes in self-concept while using SSRI antidepressants. Qual Health Res (2002) 1.06
[Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration]. Gac Sanit (2009) 1.05
Influence of mammography screening on use of mastectomies in Denmark. Acta Oncol (2014) 1.05
Sponsors' participation in conduct and reporting of industry trials: a descriptive study. Trials (2012) 1.04
Effect of screening mammography on breast cancer incidence. N Engl J Med (2013) 1.04
The impact of an electronic monitoring and reminder device on patient compliance with antihypertensive therapy: a randomized controlled trial. J Hypertens (2010) 1.03
A qualitative systematic review of morphine treatment in children with postoperative pain. Paediatr Anaesth (2007) 1.03